» Articles » PMID: 8643207

Therapeutic Efficacy of Different Antihypertensive Drugs in Human Diabetic Nephropathy: an Updated Meta-analysis

Overview
Date 1995 Oct 1
PMID 8643207
Citations 14
Authors
Affiliations
Soon will be listed here.
Citing Articles

Graphene oxide/polyvinylpyrrolidone-doped MoO nanocomposites used for dye degradation and their antibacterial activity: a molecular docking analysis.

Ikram M, Atiq I, Rafiq Butt A, Shahzadi I, Ul-Hamid A, Haider A Front Chem. 2023; 11:1191849.

PMID: 37228862 PMC: 10205020. DOI: 10.3389/fchem.2023.1191849.


Reduction in urinary albumin excretion with a moderate low-carbohydrate diet in patients with type 2 diabetes: a 12-month intervention.

Haimoto H, Sasakabe T, Umegaki H, Wakai K Diabetes Metab Syndr Obes. 2012; 5:283-91.

PMID: 22924004 PMC: 3422909. DOI: 10.2147/DMSO.S34306.


Risk factors associated with the development of overt nephropathy in type 2 diabetes patients: a 12 years observational study.

Viswanathan V, Tilak P, Kumpatla S Indian J Med Res. 2012; 136(1):46-53.

PMID: 22885263 PMC: 3461717.


Avosentan for overt diabetic nephropathy.

Mann J, Green D, Jamerson K, Ruilope L, Kuranoff S, Littke T J Am Soc Nephrol. 2010; 21(3):527-35.

PMID: 20167702 PMC: 2831858. DOI: 10.1681/ASN.2009060593.


Intratubular Renin-Angiotensin System in Hypertension.

Suzaki Y, Prieto-Carrasquero M, Kobori H Curr Hypertens Rev. 2009; 2(2):151-157.

PMID: 19789728 PMC: 2752977. DOI: 10.2174/157340206776877325.